addS

Wednesday 15 April 2015

Dental Deals and Alliances of 2014 - Worldwide Industry size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Dental Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.

Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.

Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.

Chapter 2 provides a comprehensive listing of deals by average headline, upfront, milestone and royalty rate payments

Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by most active dealmakers, top deals by value, big pharma and big biotech activity, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030

Crohns Disease Partnering 2010-2015 - Worldwide Industry size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Crohn’s disease Partnering 2010-2015 report provides understanding and access to the Crohn’s disease partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in Crohn’s disease partnering deals
Top Crohn’s disease deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

The Crohn’s Disease Partnering 2010-2015 provides understanding and access to the Crohn’s disease partnering deals and agreements entered into by the worlds leading healthcare companies.



The report provides an analysis of Crohn’s disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors Crohn’s disease technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 50 links to online copies of actual Crohn’s disease deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.


The initial chapters of this report provide an orientation of Crohn’s disease partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 3 provides an overview of the average deal terms since 2010. The chapter includes deals with a stage of development announced by headline value, upfront value, milestone value and royalty rate. Numerous tables outline financial trends.

Chapter 4 provides an overview of the most active dealmakers, top dealmakers by value, active big pharma and big biotech dealmakers including contract documents where available.

Chapter 5 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Crohn’s disease technologies and products.

Report scope

Crohn’s Disease Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to Crohn’s disease trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

Trends in Crohn’s disease dealmaking in the biopharma industry since 2010
Access to summary headline, upfront, milestone and royalty data
Access to over 50 Crohn’s disease deals
The leading Crohn’s disease deals by value since 2010

In Crohn’s Disease Partnering 2010-2015, the available deals are listed by:

Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030

Clinical Stage Partnering Terms and Agreements in Pharma and Biotech - Worldwide Industry size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the clinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter clinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.


Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This report contains over 2,000 links to online copies of actual clinical stage deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of clinical stage deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of why companies partner clinical stage compounds/products.


Chapter 3 provides an overview of clinical stage deals strategy and deal structure including numerous case studies. Chapter 4 provides an overview of the various payment strategies used in clinical stage deals.

Chapter 5 provides a review of clinical stage deal making since 2010. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 6 provides a detailed analysis of clinical stage payment terms including average headline, upfront, milestone and royalty rates for phase I, phase II and phase III deals.

Chapter 7 provides a review of the leading clinical stage deal by headline value.

Chapter 8 provides a comprehensive listing of the top 50 big pharma and big biotech companies with a brief summary followed by a comprehensive listing of clinical stage deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 9 provides a comprehensive and detailed review of clinical stage partnering deals signed and announced since 2010, where a contract document is available in the public domain. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 10 provides a comprehensive directory of clinical stage partnering deals since 2010 organized by stage of development – phase I, phase II and phase III.

The report also includes numerous tables and figures that illustrate the trends and activities in clinical stage partnering and deal making since 2010.

In addition, a comprehensive appendix is provided organized by partnering company A-Z, deal type, therapy focus and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of clinical stage products and compounds.


About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030

Tuesday 14 April 2015

Cell Therapy Deals and Alliances of 2014 - Worldwide Industry size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Cell Therapy Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.


Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.

Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.

Chapter 2 provides a comprehensive listing of leading deals by deal values, most active dealmakers, big pharma and big biotech deal activity.

Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by big pharma company profiles, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive listing of leading deals of 2014 listed by big biotech company profiles, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 5 provides a comprehensive directory of all partnering deals announced during 2014.
The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.

Executive Summary

Introduction

Chapter 1 – Trends in dealmaking during 2014
1.1 Introduction
1.2. Partnering by deal type
1.3. Partnering by industry sector
1.4. Partnering by stage of development
1.5. Partnering by technology type
1.6. Partnering by therapy area

Chapter 2 – Leading deals during 2014
2.1. Introduction
2.2 Most active partnering in 2014
2.3. Top deals by value during 2014
2.4. Big pharma dealmaking activity
2.5. Big biotech dealmaking activity

Chapter 3 – Big pharma deals during 2014
3.1. Introduction
3.2. How to use big pharma partnering deals
3.3. Big pharmapartnering company profiles
Chapter 4 – Big biotech deals during 2014
4.1. Introduction
4.2. How to use big biotech partnering deals
4.3. Big biotech partnering company profiles

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030

Animal Health Deals and Alliances of 2014 - Worldwide Industry size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Animal Health Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.

Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.


The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.

Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.

Chapter 2 provides a comprehensive listing of deals by average headline, upfront, milestone and royalty rate payments
Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by most active dealmakers and top deals by value, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014. 

The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014. In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.


Introduction

Chapter 1 – Trends in dealmaking during 2014
1.1 Introduction
1.2. Partnering by deal type
1.3. Partnering by industry sector
1.4. Partnering by stage of development
1.5. Partnering by technology type
1.6. Partnering by therapy area

Chapter 2 – Average financial deal terms
2.1 Deals by headline values
2.2 Deals by upfront payments
2.3 Deals by milestone payments
2.4 Deals by royalty rates

Chapter 3 – Leading deals during 2014
3.1. Introduction
3.2. Most active dealmakers
3.3. Top deals by value during 2014

Chapter 4 – Partnering deals directory 2014
4.1. Introduction
4.2. Partnering 2014- Company A-Z
4.3. Partnering 2014- By deal type
4.4. Partnering 2014- By stage of development
4.5. Partnering 2014 - By technology type
4.6. Partnering 2014 - By therapy area

About Wildwood Ventures
Current Partnering
Current Agreements

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030

Thursday 9 April 2015

Global Baby Electronic Toys Market 2015-2019

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

About Baby Electronic Toys

Toys and games are used for the amusement and entertainment of children. Activity toys such as building sets, dolls, puzzles, and card games help children enhance their mental agility, and develop coordination and dexterity. These are considered as recreational items that not only keep the kids engaged, but also train them. Different materials are used to manufacture toys. Electronic toys for kids such as entertainment and hobbyist robots; electronic games; and virtual babies and pets are gaining popularity. Electronic toys allow the child to learn while having fun, which helps in developing a positive attitude toward learning.


Latest analysts forecast the Global Baby Electronic Toys market to grow at a CAGR 4.01 of percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Baby Electronic Toys market for the period 2015-2019. To calculate market size, the report considers retail sales of baby electronic toys.
Latest report, the Global Baby Electronic Toys Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, Europe, and the APAC and MEA regions; it also covers the Global Baby Electronic Toys market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Key Regions

Americas
APAC
Europe
MEA
Key Vendors
Fisher-Price
Toys "R" Us
Vtech Holdings
Other Prominent Vendors
Bébé Confort
Brevi
Chicco
Hasbro
Kids II
Kiwi Baby
Mothercare
Newell Rubbermaid

Market Driver

A Large Number of Suppliers and Buyers
For a full, detailed list, view our report
Market Challenge
Stringent Government Regulations
For a full, detailed list, view our report
Market Trend
Increased Release of Licensed Toys
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030

Unified Communications and Collaboration (UC&C) Market in the EMEA Region 2015-2019

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

About Unified Communications and Collaboration

UC&C is a system that integrates the real-time communication services, such as telephony instant messaging, videoconferencing, data sharing, and others, with non-real-time communication services, such as unified messaging (e-mail, SMS, and fax). It enables an individual to send a message on one medium and receive the same message on another medium. For instance, one can receive a voicemail message and choose to access it through e-mail or a cell phone. It is used in various sectors such as Healthcare, Education, Finance and Banking, and Hospitality. It enables better collaboration by unifying different modes of communications into a single and combined user experience.


Latest analysts forecast the UC&C market in the EMEA region to grow at a CAGR of 12.31 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the UC&C market in the EMEA region for the period 2015-2019. To calculate the market size, the report considers revenue generated from UC&C software and services. In addition, the report provides the deployment model of the software and services offered by the vendors. It considers the revenue generated from the technologies used in cell phones:

Collaboration tools
Video conferencing
PBX extensions
Others: It includes customer care applications and contact center applications
Latest report, Unified Communications and Collaboration (UC&C) Market in the EMEA Region 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the UC&C market landscape in the EMEA region and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.


Key Vendors
Avaya
Cisco Systems
Microsoft
Unify
Other Prominent Vendors
8x8
Alcatel Lucent
BroadSoft
Dell
Genesys Telecommunications Laboratories
HP
Huawei Technologies
Interactive Intelligence
Jupiter Networks
Logitech International
Mitel Networks
NEC
Orange
Polycom
RingCentral
ShoreTel
Verizon Communications
Market Driver
Emergence of Cloud Solutions
For a full, detailed list, view our report
Market Challenge
Compatibility Issues with Various Components
For a full, detailed list, view our report

Market Trend

Adoption of UCaaS Technology
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

All Reports of this Category Here: http://www.researchmoz.us/ict-market-reports-96.html

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030